Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by RichyRich$on Jan 31, 2014 12:12pm
221 Views
Post# 22158560

That New CFO News Made it to the Wall Street Journal

That New CFO News Made it to the Wall Street JournalThat new CFO News also made it to the Wall Street Journal. When you Google "Sernova" it pops up on the first page, meaning a lot of people are viewing it. Hopefully it'll catch the attention of some of the Big Shots on Wall Street. They recognize the significance of that. Some people must really be trading Blind as I can't understand how someone would have a sell order at $.13 after that news! A new CFO that specializes in Mergers & Acquisitions and employee stock options at $.15 meaning they expect it to be above $.15 and a chance they could have hired the new CFO for a planned merger or acquisition. Even if no merger or acquisition it looks like she has a good resume and track record for attracting investors. https://online.wsj.com/article/PR-CO-20140131-906621.html
Bullboard Posts